Protalix BioTherapeutics (PLX) Exchange Rate Effect (2010 - 2026)
Protalix BioTherapeutics' quarterly Exchange Rate Effect came in at -$77000.0 in Q1 2026, down 862.5% year-on-year from $10098.4 in Q1 2025, and down 148.39% quarter-over-quarter from -$31000.0 in Q4 2025.
Protalix BioTherapeutics has reported Exchange Rate Effect for 17 years, with the latest figure at -$77000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 862.5% year-over-year to -$77000.0; the trailing twelve-month figure through Mar 2026 stood at -$116000.0 (down 583.33% YoY), and the FY2025 full-year result was -$47000.0, down 288.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$77000.0, down from -$31000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $54000.0 in Q4 2024, with the low at -$77000.0 in Q1 2026.
- Average Exchange Rate Effect over 5 years is -$18125.0, with a median of -$16000.0 recorded in 2024.
- Year-over-year, Exchange Rate Effect tumbled 900.0% in 2022 and soared 300.0% in 2024.
- Tracing PLX's Exchange Rate Effect over 5 years: stood at -$26000.0 in 2022, then dropped by 3.85% to -$27000.0 in 2023, then soared by 300.0% to $54000.0 in 2024, then slumped by 157.41% to -$31000.0 in 2025, then sank by 148.39% to -$77000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$77000.0 (Q1 2026), -$31000.0 (Q4 2025), and -$12000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Sep 30, 2023 | -9,000.00 |
| Sep 30, 2023 | -9,000.00 |
| Jun 30, 2023 | -36,000.00 |
| Jun 30, 2023 | -36,000.00 |
| Mar 31, 2023 | -42,000.00 |
| Mar 31, 2023 | -42,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Jun 30, 2022 | -40,000.00 |
| Jun 30, 2022 | -40,000.00 |
| Mar 31, 2022 | -11,000.00 |
| Mar 31, 2022 | -11,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -31,000.00 |
| Mar 31, 2021 | -31,000.00 |
| Dec 31, 2020 | 38,000.00 |
| Dec 31, 2020 | 38,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 44,000.00 |
| Jun 30, 2020 | 44,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Dec 31, 2019 | 8,000.00 |
| Dec 31, 2019 | 8,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Jun 30, 2019 | -2,000.00 |
| Jun 30, 2019 | -2,000.00 |
| Mar 31, 2019 | 202,000.00 |
| Mar 31, 2019 | 202,000.00 |
| Dec 31, 2018 | -140,000.00 |
| Dec 31, 2018 | -140,000.00 |
| Sep 30, 2018 | 130,000.00 |
| Sep 30, 2018 | 130,000.00 |
| Jun 30, 2018 | -157,000.00 |
| Jun 30, 2018 | -157,000.00 |
| Mar 31, 2018 | -103,000.00 |
| Mar 31, 2018 | -103,000.00 |
| Dec 31, 2017 | 125,000.00 |
| Dec 31, 2017 | 125,000.00 |
| Sep 30, 2017 | 62,000.00 |
| Sep 30, 2017 | 62,000.00 |
| Jun 30, 2017 | 56,000.00 |
| Jun 30, 2017 | 56,000.00 |
| Mar 31, 2017 | 171,000.00 |
| Mar 31, 2017 | 171,000.00 |
| Dec 31, 2016 | -154,000.00 |
| Dec 31, 2016 | -154,000.00 |
| Sep 30, 2016 | 203,000.00 |
| Sep 30, 2016 | 203,000.00 |
| Jun 30, 2016 | 15,000.00 |
| Jun 30, 2016 | 15,000.00 |
| Mar 31, 2016 | 213,000.00 |
| Mar 31, 2016 | 213,000.00 |
| Dec 31, 2015 | -21,000.00 |
| Dec 31, 2015 | -21,000.00 |
| Sep 30, 2015 | -161,000.00 |
| Sep 30, 2015 | -161,000.00 |
| Jun 30, 2015 | 340,000.00 |
| Jun 30, 2015 | 340,000.00 |
| Mar 31, 2015 | -289,000.00 |
| Mar 31, 2015 | -289,000.00 |
| Mar 31, 2014 | -29,000.00 |
| Mar 31, 2014 | -29,000.00 |
| Dec 31, 2013 | 82,000.00 |
| Dec 31, 2013 | 82,000.00 |
| Sep 30, 2013 | -24,000.00 |
| Sep 30, 2013 | -24,000.00 |
| Jun 30, 2013 | 58,000.00 |
| Jun 30, 2013 | 58,000.00 |
| Mar 31, 2013 | 110,000.00 |
| Mar 31, 2013 | 110,000.00 |
| Dec 31, 2012 | 240,000.00 |
| Dec 31, 2012 | 240,000.00 |
| Sep 30, 2012 | -76,000.00 |
| Sep 30, 2012 | -76,000.00 |
| Jun 30, 2012 | -200,000.00 |
| Jun 30, 2012 | -200,000.00 |
| Mar 31, 2012 | 163,000.00 |
| Mar 31, 2012 | 163,000.00 |
| Dec 31, 2011 | -218,000.00 |
| Dec 31, 2011 | -218,000.00 |
| Sep 30, 2011 | -319,000.00 |
| Sep 30, 2011 | -319,000.00 |
| Jun 30, 2011 | 120,000.00 |
| Jun 30, 2011 | 120,000.00 |
| Mar 31, 2011 | 29,000.00 |
| Mar 31, 2011 | 29,000.00 |
| Dec 31, 2010 | 263,000.00 |
| Dec 31, 2010 | 263,000.00 |
| Sep 30, 2010 | 372,000.00 |
| Sep 30, 2010 | 372,000.00 |